Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEAChY-M trial of intramuscular olanzapine versus droperidol for paediatric acute severe behavioural disturbance
ACTRN12621001238864Phase 3Completed
- Sponsor
- Murdoch Children's Research Institute
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in acute severe behavioural disturbance (ASBD) comparing IM olanzapine with IM droperidol (2 arms). Primary endpoint: Successful sedation without additional sedation. Started Oct 2021; status: completed.
02
Drugs
olanzapinedroperidol
03
Conditions
acute severe behavioural disturbance (ASBD)
Beyond the preview
Go deeper on ACTRN12621001238864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621001238864.